Sun.Jan 21, 2024

article thumbnail

What Are the Challenges in Moving Along Value-Based Care in Rural Communities?

MedCity News

Adoption of value-based care has been slower in rural communities. With many rural providers struggling to even stay afloat, it can be difficult to switch to value-based care, according to one healthcare executive.

article thumbnail

Inside the growing precision therapy market and the crucial role of pDNA manufacturing

Pharmaceutical Technology

CDMOs, who cater to the requirements of multiple companies and develop platform processes to achieve the much-needed economy of scale, are being seen as a possible solution.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Navigating Transformative Trends: Value-Based Care in the Spotlight for 2024

MedCity News

Here are the key trends that will need to be top of mind for provider organizations that are transitioning to VBC, or looking to improve their performance under value-based contracts.

article thumbnail

BMS eyes first-line colorectal cancer use for Opdivo-Yervoy

pharmaphorum

Bristol-Myers Squibb’s Opdivo-Yervoy regimen improves PFS as first-line therapy for patients with MSI-H/dMMR colorectal cancer in CheckMate-8HW trial

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Amgen Osteoporosis Drug Prolia Is Hit With FDA’s Strictest Warning

MedCity News

The FDA said Amgen’s Prolia may lead to low levels of calcium, or hypocalcemia. The osteoporosis drug’s black box warning follows an FDA review of Centers for Medicare & Medicaid Services studies that found Prolia led to a significant increase in the risk of severe hypocalcemia compared to treatment with an older class of medicines.

FDA 101
article thumbnail

Pharma CEOs may be subpoenaed as IRA dispute rumbles on

pharmaphorum

A vote by the HELP committee in the US on 31st January could result in the CEOs of Johnson & Johnson and Merck being forced to testify on drug pricing

Pharma 69

More Trending

article thumbnail

The Med Tech Rep Archetype: Which One Are You?

Sales Pilot Medical Sales Performance

Recently, I came across this post from my LinkedIn connection, Patrick Jamnik, President of Episurf Medical. It had me laughing out loud, first, because it’s clever and well-written, and second because it’s accurate. As someone who has presented at countless national sales meetings for medtech companies, Patrick’s humorous categorization of the different types of “guys” is spot on!

article thumbnail

How to Overcome the New Realities in Home Health Budget Strains

MedCity News

In navigating fiscal uncertainties, it is essential to acknowledge technology as a powerful ally, securing the resilience and long-term sustainability of home care for generations of patients and caregivers to follow.